Heightened Vigilance Needed When Patients Are Prescribed GLP-1 and GIP Agonists

JAMA Intern Med. 2024 Oct 1;184(10):1158-1159. doi: 10.1001/jamainternmed.2024.3732.

Tyrone A Johnson^{1

2}, Michael A Incze^{3

4}, William K Silverstein^{5

6

7}

¹ Department of Medicine, University of California, San Francisco.
² Teachable Moments Editorial Fellow, JAMA Internal Medicine.
³ Division of General Internal Medicine, University of Utah, Salt Lake City.
⁴ Section Editor, JAMA Internal Medicine.
⁵ Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁶ Division of General Internal Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
⁷ Teachable Moments Editor, JAMA Internal Medicine.

No abstract available

MeSH terms